0000000001234004

AUTHOR

Giovanna Traina

0000-0001-9996-3584

showing 5 related works from this author

Prevention of TNBS-induced colitis by probiotic supplement in mice

2014

micebusiness.industryProbioticsBioengineeringGeneral Medicinetrinitrobenzene sulfonic acidPharmacologyApplied Microbiology and Biotechnologylaw.inventionProbioticlawinflammationmicrobiotaMedicineProbiotics; microbiota; inflammation; trinitrobenzene sulfonic acid; micebusinessBiotechnologyTnbs colitis
researchProduct

COLON MICROBIAL COMPOSITION IS CORRELATED WITH THE SEVERITY OF COLITIS INDUCED BY 2,4,6-TRINITROBENZENESULFONIC ACID IN MICE

2016

The objective of this study was to evaluate the changes in some bacterial species of colonic microbiota, the clinical signs and the intestinal changes in mice with 2,4,6trinitrobenzenesulfonic acid (TNBS)-induced colitis. CD-1 male mice were randomly divided into three groups and inoculated intrarectally with saline, ethanol or TNBS solutions. Ethanol and TNBS treatments induced weight loss accompanied by mild and severe inflammation of the colon mucosa, respectively. However, TNBS-treated mice displayed significant differences compared to the saline group in terms of disease activity index and histological scoring. Both ethanol and TNBS groups showed an increased prevalence of Escherichia …

lcsh:R5-920animal diseaseslcsh:Medicine (General)digestive systemdigestive system diseasesEuromediterranean Biomedical Journal
researchProduct

Potential benefits of colostrum in gastrointestinal diseases

2016

This paper reviews the composition of colostrum and the potential preventive and therapeutic use of this "first milk" for treating various gastrointestinal disorders in humans. Colostrum is a complex biological liquid that is richer in antimicrobial peptides, immune-regulating compounds and growth factors than the subsequent mature milk. The main functions of colostrum are to provide essential nutritional components, strengthen the natural defense system, modulate immune response, balance intestinal microbiota and enhance the growth and repair of several tissues. Several studies and clinical trials carried out both in vitro and in vivo on humans and animals suggest the clinical benefits of …

0301 basic medicineGastrointestinal Diseasesanimal diseasesAntimicrobial peptidesPhysiologyGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesImmune systemfluids and secretionsImmunityIn vivogastrointestinal diseases dysbiosis colostrumMedicineAnimalsHumansClinical significanceColostrum Anti-Microbical Factors Immunity Growth Factors Intestinal Disorders ReviewGeneral Immunology and Microbiologybusiness.industryColostrumfood and beveragesmedicine.diseaseClinical trial030104 developmental biologyDietary SupplementsColostrumCattleFemalebusinessDysbiosis
researchProduct

Validation of a modified model of TNBS-induced colitis in rats. How to induce a chemical colitis in rats

2014

Background: there are no standard practice in the induction of colitis by 2,4,6-trinitrobenzene sulfonic (TNBS) acid. Usually, the repeated administration of TNBS is preferred, because it will result in a local Th1 response that has the characteristics of Crohn's disease. material and Methods: A total of 30 rats were randomized into two groups, consisting of a saline control group of ten rats and a TNBS groups of 20 rats. After the animals were anesthesized, 0,5 ml of either 0,9 % saline 8controls) or TNBS 50 mg/Kg dissolved in 50% ethanol were instilled into the colon through a rubber catheter. The experiment was repeated weekly for four weeks, then, the rats were killed at day 40, and the…

MaleSettore MED/12 - GastroenterologiaSettore MED/09 - Medicina InternaSettore MED/06 - Oncologia MedicaCrohn's disease colitis induced TNBS induction colitis 246-trinitrobenzene sulfonic acid (TNBS)Reproducibility of ResultsSettore MED/08 - Anatomia PatologicaColitisRatsDisease Models AnimalSettore MED/18 - Chirurgia GeneraleInstillation DrugTrinitrobenzenesulfonic AcidAnimalsRats Wistar
researchProduct

NUTRITION IN IBD PATIENT'S: WHAT ARE THE PROSPECTS?

2015

Summary: Inflammatory Bowel Disease (IBD) is a chronic disorder characterized by a relapsing-remitting course, which alternates between active and quiescent states, ultimately impairing a patients quality of life. The two main types of IBD are Crohn's disease (CD) and Ulcerative Colitis (UC). In physiological conditions the gut is costantly exposed to various antigens, commensal microflora and pathogens and the inflammatory response is finely balanced. It is thought that a vast number of environmental risk factors may be implicated in the development of IBD, including smoking factors, dietary factors, psycological stress, use of non-steroidal anti-inflammatory drugs and oral contraceptives,…

Settore MED/04 - Patologia GeneraleSettore MED/18 - Chirurgia GeneraleSettore MED/09 - Medicina Internainflammatory bowel disease IBD nutrition microbiome dysbiosis
researchProduct